MODY
7
2
2
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
Usefulness of Continuous Glucose Monitoring in MODY Diagnosis
Genomic Study of Young-Onset Diabetes Mellitus
Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
Identifying Maturity-onset Diabetes of the Young in Emirati Patients
A Feasibility Study of a 12 Week Training Intervention With Patients With Type 2 Diabetes and MODY in Greenland
Screening for Genetic Forms of Diabetes in Convention of Care for Children and Adolescents With Diabetes (GENEPEDIAB)
Genetic Causes of Gestational Diabetes in the Emirati Population